Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Seres Therapeutics logo

Seres Therapeutics

Recent Finacing

Series D

Recent Raise

$65M

Seres Health is a clinical-stage microbiome therapeutics platform developing Ecobiotic biological drugs, including lead candidate SER-109 for recurrent C. difficile, with a pipeline across infectious, metabolic, and inflammatory diseases.

Founded 2010
Massachusetts, United States
101-250
Publicly Traded
serestherapeutics.com

Highlights

Focus Areas

Biopharma
Biotechnology
Health Care
Therapeutics

Recent Investors

Flagship Ventures logo
Nestl Health Science logo
Enso Ventures logo
Alexandria Venture Investments logo
Mayo Clinic logo

Financials

$133.5M

Total Raised

4

Funding rounds

5

Investors